Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer

BACKGROUND: Bacillus Calmette-Guerin (BCG) is the most effective intravesical therapy for non-muscle invasive bladder cancer (NMIBC), but patients can fail or supply shortages can develop. For BCG failures, radical cystectomy is recommended. However, in patients who desire bladder preservation or ar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Bladder Cancer
Autores principales: Steinberg, Ryan L., Thomas, Lewis J., O’Donnell, Michael A., Nepple, Kenneth G.
Formato: Artigo
Lenguaje:Inglês
Publicado: IOS Press 2015
Materias:
Research Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6218180/
https://ncbi.nlm.nih.gov/pubmed/30561441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-150008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares